Key result
Cardiac resynchronization therapy reduces mortality and hospitalizations in patients with either more or less symptomatic heart failure.
Why the study?
Does cardiac resynchronization therapy reduce mortality and hospitalizations in patients with either more or less symptomatic HF?
Does cardiac resynchronization therapy reduce mortality and hospitalizations in patients with either more or less symptomatic HF?
Cardiac resynchronization therapy is effective in reducing mortality and hospitalizations even in patients with less symptomatic heart failure.
Answers are grounded in this paper and cite their sources.
Supports broader CRT eligibility in HF; extends trial evidence to less symptomatic patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Adrian F. Hernandez (2011) studied this question. Cardiac resynchronization therapy reduces mortality and hospitalizations in patients with either more or less symptomatic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: